Follow Us on StockTwits

Analyst Actions and Breaking News

Posted by on March 10, 2017 9:07 AM
Tags:
Categories: Business

Overnight Analyst Actions:

Raised: None

Initiates:

IIIN Buy Long Bow Research

Cuts:

CHKE Neutral B. Riley & Co.
IONS Sell Goldman Sachs & Co

Overnight Headlines By Ticker:

ABBV AbbVie Inc.

3/10 06:09 Goldman Sachs Adds to Conviction Buy List; price target raised to $80 from $74

AGEN Agenus Inc.

3/10 07:18 JMP Securities Reiterates AGEN with Market Outperform, price target: $15

AVGO Broadcom Ltd (merged in 2016)

3/10 07:09 Barclays Reiterates AVGO with Overweight, price target: $250

CHKE Cherokee Inc.

3/10 01:58 B. Riley & Co. Cuts CHKE to Neutral from Buy

FNSR Finisar Corp

3/10 02:47 Jefferies Reiterates FNSR with Hold, price target: $32

3/9 16:01 Reports Q3 $0.59 v $0.61e, R$380.6M v $389Me

GLD StreetTracks Gold Trust

3/9 19:50 Apr Gold extending decline below $1,200; 5-week lows

3/9 17:08 SPDR Gold Trust ETF daily holdings fall 2.7 tonnes to 834.1 tonnes; lowest since Feb 9th; 3rd straight decline

GRUB Grubhub Seamless Inc

3/10 06:08 Caledonia Investments Pty Limited discloses passive 10.8% stake – 13G filing

IIIN InSteel Industries, Inc.

3/10 00:10 Long Bow Research Initiates IIIN with Buy, price target: $42

IONS Ionis Pharmaceuticals, Inc.

3/10 05:50 Goldman Sachs Cuts IONS to Sell from Neutral, price target: $25

IRWD Ironwood Pharmaceuticals

3/10 06:07 BTIG Reiterates IRWD with Buy, price target: $21

JBLU JetBlue Airways Corp

3/10 08:00 Reports Feb load factor 82.6% – 0.5% y/y

LKQ LKQ Corporation

3/9 17:02 Names CFO Dominick Zarcone as new CEO; effective immediately

MYL Mylan Laboratories Inc

3/10 07:30 Launches Generic Pristiq Tablets

3/10 07:10 Barclays Reiterates MYL with Equal Weight, price target: $47

OCUL Ocular Therapeutix

3/10 07:30 Reports Q4 -$0.52 v -$0.47e, R$0.5M v $0.4M y/y

SRPT Sarepta Therapeutics

3/10 01:07 JPMorgan Chase and Co Reiterates SRPT with Overweight, price target: $42

TGLS Tecnoglass Inc

3/10 07:00 Reports Q4 $0.15 v $0.19e, R$80.3M v $70.0Me

VCEL Vericel Corporation

3/10 07:15 Reports Q4 -$0.34 v -$0.22e, R$16.5M v $15.4M y/y

VRX Valeant Pharmaceuticals International

3/10 06:30 Upsizes $3.25B senior secured notes offering (prior $2.5B)

ZFGN Zafgen, Inc

3/10 07:20 JMP Securities Reiterates ZFGN with Market Outperform, price target: $8

3/9 16:06 Reports Q4 -$0.38 v -$0.56e, Rev is nil